Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$151.71
-0.40-0.26%
À la fermeture: -
$151.51
-0.20-0.13%
Après les heures de négociation: 7:39 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Chevron Corp a un objectif de cours consensus de $172.91, basé sur les évaluations des 24 analystes. Le plus élevé est de $201 attribué par Morgan Stanley le octobre 17, 2023, et le plus bas est de $124 attribué par Redburn Atlantic le avril 23, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Scotiabank, Barclays et Mizuho le octobre 9, 2025, octobre 7, 2025 et septembre 15, 2025. Avec un objectif de cours moyen de $171.33 entre Scotiabank, Barclays et Mizuho, il y a une variation implicite de 13.08% upside pour Chevron Corp à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Scotiabank
Barclays
Mizuho
B of A Securities
UBS
1calculé à partir des notes des analystes
Notes d'analystes pour Chevron
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/09/2025 | 8.9% | Scotiabank | $160 → $165 | Maintains | Sector Perform | |||
10/07/2025 | 4.28% | Barclays | $160 → $158 | Maintains | Equal-Weight | |||
09/15/2025 | 26.06% | Mizuho | $192 → $191 | Maintains | Outperform | |||
09/10/2025 | 22.1% | B of A Securities | $170 → $185 | Maintains | Buy | |||
08/20/2025 | 30.02% | UBS | $186 → $197 | Maintains | Buy | |||
08/20/2025 | 2.3% | Melius Research | → $155 | Initiates | → Hold | |||
08/18/2025 | 10.88% | Piper Sandler | $164 → $168 | Maintains | Overweight | |||
08/13/2025 | 26.72% | Mizuho | $186 → $192 | Maintains | Outperform | |||
08/04/2025 | 22.76% | UBS | $177 → $186 | Maintains | Buy | |||
07/31/2025 | 18.8% | Evercore ISI Group | → $180 | Reinstates | → Outperform | |||
07/23/2025 | 17.48% | Wells Fargo | $165 → $178 | Maintains | Overweight | |||
07/11/2025 | 5.6% | Scotiabank | $143 → $160 | Maintains | Sector Perform | |||
07/07/2025 | 2.96% | Barclays | $152 → $156 | Maintains | Equal-Weight | |||
07/02/2025 | 8.24% | Piper Sandler | $162 → $164 | Maintains | Overweight | |||
06/26/2025 | 8.9% | Wells Fargo | $164 → $165 | Maintains | Overweight | |||
05/13/2025 | 6.92% | Piper Sandler | $173 → $162 | Maintains | Overweight | |||
05/13/2025 | 4.28% | HSBC | $176 → $158 | Downgrade | Buy → Hold | |||
05/13/2025 | 22.76% | Mizuho | $188 → $186 | Maintains | Outperform | |||
05/05/2025 | 8.24% | Wells Fargo | $173 → $164 | Maintains | Overweight | |||
04/23/2025 | -18.16% | Redburn Atlantic | $156 → $124 | Downgrade | Neutral → Sell | |||
04/23/2025 | 0.32% | Barclays | $171 → $152 | Downgrade | Overweight → Equal-Weight | |||
04/15/2025 | 24.08% | Mizuho | $203 → $188 | Maintains | Outperform | |||
04/15/2025 | 14.18% | Wells Fargo | $184 → $173 | Maintains | Overweight | |||
04/11/2025 | -5.62% | Scotiabank | $160 → $143 | Downgrade | Sector Outperform → Sector Perform | |||
04/07/2025 | 22.1% | UBS | $194 → $185 | Maintains | Buy | |||
02/05/2025 | 33.98% | Mizuho | $194 → $203 | Maintains | Outperform | |||
02/05/2025 | 12.86% | Barclays | $174 → $171 | Maintains | Overweight | |||
02/04/2025 | 5.6% | Truist Securities | $164 → $160 | Maintains | Hold | |||
02/03/2025 | 28.04% | UBS | $195 → $194 | Maintains | Buy | |||
02/03/2025 | 15.5% | RBC Capital | $175 → $175 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 21.44% | Wells Fargo | $188 → $184 | Maintains | Overweight | |||
02/03/2025 | 15.5% | Raymond James | $180 → $175 | Maintains | Outperform | |||
01/17/2025 | 18.8% | Raymond James | $175 → $180 | Maintains | Outperform | |||
01/13/2025 | 8.24% | Truist Securities | $160 → $164 | Maintains | Hold | |||
12/19/2024 | 14.18% | Piper Sandler | $184 → $173 | Maintains | Overweight | |||
12/09/2024 | 24.08% | Wells Fargo | $171 → $188 | Maintains | Overweight | |||
12/06/2024 | 5.6% | Truist Securities | $155 → $160 | Maintains | Hold | |||
12/03/2024 | 28.7% | UBS | $194 → $195 | Maintains | Buy | |||
11/26/2024 | 22.1% | Citigroup | $145 → $185 | Upgrade | Neutral → Buy | |||
11/07/2024 | 28.04% | Mizuho | $189 → $194 | Maintains | Outperform | |||
11/04/2024 | 28.04% | UBS | $192 → $194 | Maintains | Buy | |||
11/04/2024 | 15.5% | RBC Capital | $170 → $175 | Maintains | Outperform | |||
11/04/2024 | 2.3% | Truist Securities | $150 → $155 | Maintains | Hold | |||
11/04/2024 | 14.84% | Barclays | $168 → $174 | Maintains | Overweight | |||
10/17/2024 | 10.88% | B of A Securities | → $168 | Reinstates | → Buy | |||
10/10/2024 | 7.58% | Scotiabank | $180 → $163 | Maintains | Sector Outperform | |||
10/08/2024 | 26.72% | UBS | $189 → $192 | Maintains | Buy | |||
10/08/2024 | 12.2% | RBC Capital | $170 → $170 | Reiterates | Outperform → Outperform | |||
10/03/2024 | 10.88% | Barclays | $185 → $168 | Maintains | Overweight | |||
09/30/2024 | -1% | Truist Securities | $154 → $150 | Maintains | Hold | |||
09/27/2024 | 11.54% | Wells Fargo | $196 → $169 | Maintains | Overweight | |||
09/18/2024 | 24.74% | UBS | $192 → $189 | Maintains | Buy | |||
09/16/2024 | 24.74% | Mizuho | $205 → $189 | Maintains | Outperform | |||
08/06/2024 | 22.1% | Barclays | $203 → $185 | Maintains | Overweight | |||
08/05/2024 | 18.8% | RBC Capital | $190 → $180 | Maintains | Outperform | |||
08/05/2024 | 1.64% | Truist Securities | $156 → $154 | Maintains | Hold | |||
07/22/2024 | 2.96% | Truist Securities | $166 → $156 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/17/2024 | 10.22% | Bernstein | $183 → $167 | Downgrade | Outperform → Market Perform | |||
07/12/2024 | 18.8% | Scotiabank | $195 → $180 | Maintains | Sector Outperform | |||
05/13/2024 | 35.3% | Mizuho | $200 → $205 | Maintains | Buy | |||
05/10/2024 | 9.56% | Truist Securities | $156 → $166 | Maintains | Hold | |||
04/30/2024 | 17.48% | HSBC | $175 → $178 | Maintains | Buy | |||
04/30/2024 | 35.96% | Wells Fargo | $198 → $206 | Maintains | Overweight | |||
04/29/2024 | 5.6% | TD Cowen | $155 → $160 | Maintains | Hold | |||
04/18/2024 | 34.64% | Piper Sandler | $180 → $204 | Maintains | Overweight | |||
04/15/2024 | 14.84% | Raymond James | $170 → $174 | Maintains | Outperform | |||
04/11/2024 | 28.7% | Scotiabank | $170 → $195 | Upgrade | Sector Perform → Sector Outperform | |||
04/10/2024 | 33.98% | Barclays | → $203 | Initiates | → Overweight | |||
04/09/2024 | 30.02% | UBS | $185 → $197 | Maintains | Buy | |||
04/05/2024 | 2.96% | Truist Securities | $168 → $156 | Maintains | Hold | |||
04/04/2024 | 30.68% | Wells Fargo | $185 → $198 | Maintains | Overweight | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
03/20/2024 | 32% | Mizuho | $195 → $200 | Maintains | Buy | |||
03/14/2024 | 18.8% | Piper Sandler | $188 → $180 | Maintains | Overweight | |||
02/06/2024 | 5.6% | DZ Bank | → $160 | Downgrade | Buy → Hold | |||
02/05/2024 | 25.4% | RBC Capital | $185 → $190 | Maintains | Outperform | |||
01/23/2024 | -1% | TD Cowen | $170 → $150 | Downgrade | Outperform → Market Perform | |||
01/16/2024 | 12.2% | Scotiabank | → $170 | Downgrade | Sector Outperform → Sector Perform | |||
01/08/2024 | 21.44% | Jefferies | → $184 | Upgrade | Hold → Buy | |||
12/14/2023 | 22.1% | UBS | $194 → $185 | Maintains | Buy | |||
11/14/2023 | 28.7% | Mizuho | $215 → $195 | Maintains | Buy | |||
11/02/2023 | 20.12% | Bernstein | $184 → $182 | Upgrade | Market Perform → Outperform | |||
10/30/2023 | 32% | B of A Securities | $190 → $200 | Upgrade | Neutral → Buy | |||
10/30/2023 | 15.5% | Raymond James | $200 → $175 | Maintains | Outperform | |||
10/24/2023 | 11.54% | Truist Securities | $175 → $169 | Maintains | Hold | |||
10/24/2023 | 18.8% | RBC Capital | → $180 | Reiterates | Outperform → Outperform | |||
10/17/2023 | 32.66% | Morgan Stanley | $203 → $201 | Maintains | Equal-Weight | |||
10/17/2023 | 21.44% | Bernstein | → $184 | Initiates | → Market Perform | |||
10/04/2023 | 38.6% | UBS | $209 → $210 | Maintains | Buy | |||
10/02/2023 | 33.98% | Morgan Stanley | $198 → $203 | Maintains | Equal-Weight | |||
09/18/2023 | 41.9% | Mizuho | $209 → $215 | Maintains | Buy | |||
08/18/2023 | 30.68% | Morgan Stanley | $197 → $198 | Maintains | Equal-Weight | |||
08/17/2023 | 37.94% | UBS | $202 → $209 | Maintains | Buy | |||
08/16/2023 | — | Mizuho | — | Upgrade | Neutral → Buy | |||
08/01/2023 | 23.42% | Goldman Sachs | $166 → $187 | Maintains | Buy | |||
07/31/2023 | 8.9% | Truist Securities | $163 → $165 | Maintains | Hold | |||
07/31/2023 | 23.42% | Goldman Sachs | → $187 | Upgrade | Neutral → Buy | |||
07/25/2023 | 30.02% | Morgan Stanley | $197 → $197 | Reiterates | Equal-Weight → Equal-Weight | |||
07/20/2023 | 33.32% | UBS | $207 → $202 | Maintains | Buy |
FAQ
Quel est le cours indicatif de l'action Chevron (CVX) ?
Le dernier objectif de prix pour Chevron (NYSE:CVX) a été rapporté par Scotiabank le octobre 9, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $165.00 s'attendant à ce que CVX se rise dans les 12 prochains mois (un possible changement de 8.90% upside). 44 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Chevron (CVX) ?
La dernière note d'analyste pour Chevron (NYSE:CVX) a été fournie par Scotiabank, et Chevron maintenu leur note sector perform.
Quand a eu lieu la dernière mise à niveau pour Chevron (CVX) ?
La dernière amélioration pour Chevron Corp a eu lieu le novembre 26, 2024 lorsque Citigroup a augmenté leur objectif de prix à $185. Citigroup avait précédemment a neutral pour Chevron Corp.
Quand a eu lieu la dernière dégradation pour Chevron (CVX) ?
La dernière réduction pour Chevron Corp a eu lieu le mai 13, 2025 lorsque HSBC a changé leur objectif de prix de $176 à $158 pour Chevron Corp.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Chevron (CVX) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Chevron, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Chevron a été déposée le octobre 9, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 9, 2026.
La note d'analyste pour Chevron (CVX) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Chevron (CVX) était un maintenu avec un objectif de prix de $160.00 à $165.00. Le prix actuel de Chevron (CVX) est de $151.51, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.